Dapavel M 5mg/1000mg Tablet ER
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (5mg) + Metformin (1000mg)
Overview Dapavel M 5mg/1000mg Tablet ER
Dapavel M 5mg/1000mg Extended-Release tablets combine two medications to manage type 2 diabetes. This treatment helps regulate elevated blood glucose, lessening the risk of serious diabetic complications and contributing to heart health. Dapavel M can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation to avoid potentially dangerous spikes in blood sugar leading to complications such as kidney impairment or vision loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Common side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration is recommended to prevent dehydration. Genital yeast infections are a possibility; meticulous hygiene can minimize this risk. Prior to commencing treatment, disclose any kidney or liver disease, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption as it might heighten certain side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapavel M 5mg/1000mg Tablet ER
No information provided. Please provide the text you wish me to rewrite.
Uses of Dapavel M 5mg/1000mg Tablet ER
Managing type 2 diabetes
Major Benefits of Dapavel M 5mg/1000mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapavel M 5mg/1000mg Extended-Release tablet whole; do not crush, chew, or break it. Administer this medication with food.
Common Side effects of Dapavel M 5mg/1000mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapavel M 5mg/1000mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Dapavel M 5mg/1000mg Extended-Release tablets should be taken with a meal.
How Dapavel M 5mg/1000mg Tablet ER works:
Dapagliflozin and Metformin, combined as Dapavel M 5mg/1000mg Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action optimizes blood sugar regulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Dapavel M 5mg/1000mg extended-release tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dapavel M 5mg/1000mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapavel M 5mg/1000mg tablets are likely not suitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Individuals with kidney impairment should use Dapavel M 5mg/1000mg Extended-Release tablets cautiously. Dosage modification of Dapavel M 5mg/1000mg Extended-Release tablets might be necessary. Medical advice is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Dapavel M 5mg/1000mg Extended-Release tablets. Dosage modification of Dapavel M 5mg/1000mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Dapavel M 5mg/1000mg Tablet ER :
Should you forget to take your Dapavel M 5mg/1000mg Extended-Release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapavel M 5mg/1000mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |



